June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Investigation of intermediate AMD with MAIA microperimetry metrics by the PINNACLE Consortium
Author Affiliations & Notes
  • Philipp Anders
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Basel-Stadt, Switzerland
    Department of Ophthalmology, Universitat Basel Medizinische Fakultat, Basel, Basel-Stadt, Switzerland
  • Ghislaine L Traber
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Basel-Stadt, Switzerland
  • Ahmed M Hagag
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
    University College London Institute of Ophthalmology, London, London, United Kingdom
  • Sophie Riedl
    Laboratory of Ophthalmic Image Analysis, Medizinische Universitat Wien Universitatsklinik fur Augenheilkunde und Optometrie, Wien, Wien, Austria
  • Lars Fritsche
    Center for Statistical Genetics, Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan, United States
  • Daniel Rueckert
    Imperial College London, London, London, United Kingdom
  • Ursula Schmidt-Erfurth
    Laboratory of Ophthalmic Image Analysis, Medizinische Universitat Wien Universitatsklinik fur Augenheilkunde und Optometrie, Wien, Wien, Austria
  • Sobha Sivaprasad
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Andrew J Lotery
    University of Southampton Faculty of Medicine, Southampton, Southampton, United Kingdom
  • Hendrik P Scholl
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Basel-Stadt, Switzerland
    Department of Ophthalmology, Universitat Basel Medizinische Fakultat, Basel, Basel-Stadt, Switzerland
  • Footnotes
    Commercial Relationships   Philipp Anders None; Ghislaine L Traber None; Ahmed Hagag None; Sophie Riedl None; Lars Fritsche None; Daniel Rueckert None; Ursula Schmidt-Erfurth None; Sobha Sivaprasad None; Andrew Lotery Novartis, Allergan, Apellis, Code C (Consultant/Contractor), Gyroscope Therapeutics, Code I (Personal Financial Interest); Hendrik Scholl None
  • Footnotes
    Support  Wellcome Trust grant [210572/Z/18/Z]
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 876. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Philipp Anders, Ghislaine L Traber, Ahmed M Hagag, Sophie Riedl, Lars Fritsche, Daniel Rueckert, Ursula Schmidt-Erfurth, Sobha Sivaprasad, Andrew J Lotery, Hendrik P Scholl; Investigation of intermediate AMD with MAIA microperimetry metrics by the PINNACLE Consortium. Invest. Ophthalmol. Vis. Sci. 2022;63(7):876.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Microperimetry (MP) is an important technique to evaluate visual performance in patients with age-related macular degeneration (AMD). In this study we examine a large cohort of patients with intermediate AMD (iAMD) with multiple MP retinal sensitivity and fixation stability metrics.

Methods : This is a cross-sectional analysis of baseline data from 247 patient eyes of the longitudinal, prospective, multicenter and non-interventional PINNACLE study. Best Corrected Visual Acuity (BCVA) and Low Luminance Visual Acuity (LLVA) were measured with ETDRS charts. The MAIA (Centervue, Italy) MP metrics of mean sensitivity (MS), Bivariate Contour Ellipse Area (BCEA) fixation indices (63% and 95%) and percentage of fixation points within 1° and 2° of the foveal center (P1 and P2) were recorded. R code by Josan et al., was applied to obtain 3-D hill of vision surface plots and the total volume (VTOT) beneath the plots in dB-deg2. We report non-normally distributed data with Spearman’s R, medians and interquartile ranges (IQRs).

Results : The following baseline medians and IQRs were measured: BVCA LogMAR 0.02 (-0.06-0.1), LLVA LogMAR 0.32 (0.2-0.45), VTOT 1656 dB-deg2 (1541-1761), MS 24.2 dB (22.8-25.7), P1 93% (82-98), P2 99% (94-100), BCEA63 1 deg2 (0.4-2.7), BCEA95 2.9 deg2 (1.2-8.1). There was a significant positive correlation for VTOT and MS (r = 0.98; p < 0.0001). VTOT exhibited a significant correlation to all MAIA metrics of fixation stability (p < 0.05). All metrics of fixation stability were significantly correlated with each other (p < 0.0001). All MAIA metrics were significantly correlated to BCVA and LLVA (p < 0.01). The performances in most sensitivity and fixation metrics were significantly inversely correlated to age (BCVA: r = 0.33, p < 0.0001; LLVA: r = 0.33, p < 0.0001; VTOT: r = -0.28, p < 0.0001; MS: r = -0.29, p < 0.0001; P1: r = -0.16, p = 0.01; BCEA63: r = 0.19, p = 0.003; BCEA95: r = 0.19, p = 0.03).

Conclusions : We report reference data for multiple retinal sensitivity and fixation stability metrics in a large cohort of patients with iAMD. Our analysis provides a strong positive correlation between MS, an established metric, and VTOT , a novel volumetric description of retinal sensitivity. The latter might be more precise, since it eliminates the inaccuracy of averaging. Finally, our data provide evidence for the inverse correlation of retinal functional capacities and age in iAMD.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×